These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 31488180)

  • 21. AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin.
    Chen C; Cai Q; He W; Lam TB; Lin J; Zhao Y; Chen X; Gu P; Huang H; Xue M; Liu H; Su F; Huang J; Zheng J; Lin T
    Cell Death Dis; 2017 Oct; 8(10):e3060. PubMed ID: 28981098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression.
    Zhao M; Qi M; Li X; Hu J; Zhang J; Jiao M; Bai X; Peng X; Han B
    Prostate; 2019 Apr; 79(5):480-488. PubMed ID: 30609075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X; Wang Y; Ning Y
    Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition.
    Lee YC; Lin SC; Yu G; Zhu M; Song JH; Rivera K; Pappin DJ; Logothetis CJ; Panaretakis T; Wang G; Yu-Lee LY; Lin SH
    Oncogene; 2022 Feb; 41(6):757-769. PubMed ID: 34845375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.
    Lv DJ; Song XL; Huang B; Yu YZ; Shu FP; Wang C; Chen H; Zhang HB; Zhao SC
    Theranostics; 2019; 9(18):5166-5182. PubMed ID: 31410208
    [No Abstract]   [Full Text] [Related]  

  • 27. PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
    Fan J; Fan Y; Wang X; Niu L; Duan L; Yang J; Li L; Gao Y; Wu X; Luo C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):337. PubMed ID: 31383001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
    Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
    Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insight into prostate cancer osteolytic metastasis by RelB coordination of IL-8 and S100A4.
    Sun W; Xu K; Li X; Qian P; Xu F; Zhang Y; Wang X; Xu Z; Ding J; Xu X; Wei X; Jiang Q; Xu Y
    Clin Transl Med; 2024 Oct; 14(10):e70058. PubMed ID: 39415352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis.
    Tseng JC; Huang SH; Lin CY; Wang BJ; Huang SF; Shen YY; Chuu CP
    Cell Death Dis; 2020 May; 11(5):376. PubMed ID: 32415173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
    Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
    Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myc-Associated Zinc Finger Protein Promotes Metastasis of Papillary Thyroid Cancer.
    Zheng C; Wu H; Zhang S; Tian R; Long H; Zhang H; Guo X; Li D; Tan S; Zhu X
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):162. PubMed ID: 37664917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrachromosomal circular DNA promotes prostate cancer progression through the FAM84B/CDKN1B/MYC/WWP1 axis.
    Jin W; Xu Z; Song Y; Chen F
    Cell Mol Biol Lett; 2024 Jul; 29(1):103. PubMed ID: 38997648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.
    Ward Y; Wang W; Woodhouse E; Linnoila I; Liotta L; Kelly K
    Mol Cell Biol; 2001 Sep; 21(17):5958-69. PubMed ID: 11486034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway.
    Lv C; Fu S; Dong Q; Yu Z; Zhang G; Kong C; Fu C; Zeng Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):24. PubMed ID: 30658679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT.
    Peng X; Guo W; Liu T; Wang X; Tu X; Xiong D; Chen S; Lai Y; Du H; Chen G; Liu G; Tang Y; Huang S; Zou X
    PLoS One; 2011; 6(5):e20341. PubMed ID: 21647377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property.
    Cogoi S; Shchekotikhin AE; Xodo LE
    Nucleic Acids Res; 2014 Jul; 42(13):8379-88. PubMed ID: 25013182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.
    Chen W; Zhou P; Li X
    Int J Mol Med; 2016 Jun; 37(6):1551-7. PubMed ID: 27121695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling.
    Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
    J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.